Dr. Perlis currently consults with Anavex Pharmaceuticals and is an expert advisor for Gerson Lehman Group and Guidepoint.

 

His work is largely focused on the sleep effects of drugs and devices that are in development.

  • Sanofi

  • Merck 

  • Eisai

  • Actelion

  • Takeda

  • Nexalin

  • Lumosity

  • MedQuery Advisors

  • Intelligentsia Consulting

  • InsomniSolv